Dr. Mary Feng, MD

Claim this profile

University of California, San Francisco

Studies Liver Cancer
Studies Esophageal Adenocarcinoma
2 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.

University Of California, San Francisco

Clinical Trials Mary Feng, MD is currently running

Image of trial facility.

Radiation Therapy

for Gastrointestinal Cancer

This phase II trial studies how well radiation therapy works for the treatment of gastrointestinal cancer that are spreading to other places in the body (metastatic). Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. This trial is being done to determine if giving radiation therapy to patients who are being treated with immunotherapy and whose cancers are progressing (getting worse) can slow or stop the growth of their cancers. It may also help researchers determine if giving radiation therapy to one tumor can stimulate the immune system to attack other tumors in the body that are not targeted by the radiation therapy.

Recruiting

1 award

N/A

14 criteria

Image of trial facility.

Radiotherapy + Immunotherapy

for Liver Cancer

This phase II trial studies how well standard of care hypofractionated radiation therapy followed by durvalumab with or without tremelimumab works in treating patients with hepatocellular cancer (liver cancer) that has spread to other places in the body (advanced) and that is growing, spreading, or getting worse (progressing). In some patients, cancer cells and immune cells start to express signals that stop the body's immune system from killing the cancer. New drugs being developed, such as durvalumab and tremelimumab, are designed to target and block these signals and may help increase the immune response to prevent or slow down cancer growth. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may help the immune system work even better. Giving durvalumab with or without tremelimumab after radiation therapy may work better than radiation therapy alone in treating patients with liver cancer.

Recruiting

1 award

Phase 2

More about Mary Feng, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Mary Feng, MD has experience with

  • Radiation Therapy
  • Durvalumab
  • Hypofractionated Radiation Therapy
  • Tremelimumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mary Feng, MD specialize in?

Is Mary Feng, MD currently recruiting for clinical trials?

Are there any treatments that Mary Feng, MD has studied deeply?

What is the best way to schedule an appointment with Mary Feng, MD?

What is the office address of Mary Feng, MD?

Is there any support for travel costs?